S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TLSI TriSalus Life Sciences Inc

4.93

0.10 (2.07%)

Jan 17 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

TriSalus Life Sciences (NASDAQ:TLSI)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more TriSalus Life Sciences Charts.

TriSalus Life Sciences (NASDAQ:TLSI)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more TriSalus Life Sciences Charts.

TriSalus Life Sciences Inc News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Friday 10 January 2025 (1 week ago) • Edgar (US Regulatory)

TriSalus Reports Q3 2024 Financial Results and Provides Business Update
Thursday 14 November 2024 (2 months ago) • Business Wire

TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
Monday 11 November 2024 (2 months ago) • Business Wire

TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment
Thursday 7 November 2024 (2 months ago) • Business Wire

TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call
Thursday 31 October 2024 (3 months ago) • Business Wire

TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
Monday 14 October 2024 (3 months ago) • Business Wire

TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board
Thursday 26 September 2024 (4 months ago) • Business Wire

TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System
Monday 23 September 2024 (4 months ago) • Business Wire

TriSalus Reports Q2 2024 Financial Results and Business Update
Thursday 15 August 2024 (5 months ago) • Business Wire

TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call
Thursday 1 August 2024 (6 months ago) • Business Wire

TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation
Monday 1 July 2024 (7 months ago) • Business Wire

TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants
Wednesday 26 June 2024 (7 months ago) • Business Wire

More TriSalus Life Sciences Inc News Articles

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions